Texas Permanent School Fund lowered its position in shares of Exponent Inc. (NASDAQ:EXPO) by 0.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,794 shares of the company’s stock after selling 52 shares during the period. Texas Permanent School Fund owned about 0.07% of Exponent worth $1,011,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Great West Life Assurance Co. Can boosted its position in Exponent by 3.4% in the third quarter. Great West Life Assurance Co. Can now owns 35,203 shares of the company’s stock worth $1,796,000 after buying an additional 1,151 shares during the last quarter. Roffman Miller Associates Inc. PA boosted its stake in shares of Exponent by 5.5% in the third quarter. Roffman Miller Associates Inc. PA now owns 139,342 shares of the company’s stock valued at $7,115,000 after buying an additional 7,220 shares in the last quarter. Nationwide Fund Advisors boosted its stake in shares of Exponent by 11.4% in the third quarter. Nationwide Fund Advisors now owns 152,282 shares of the company’s stock valued at $7,776,000 after buying an additional 15,599 shares in the last quarter. GW&K Investment Management LLC boosted its stake in shares of Exponent by 20.2% in the third quarter. GW&K Investment Management LLC now owns 380,060 shares of the company’s stock valued at $19,406,000 after buying an additional 63,984 shares in the last quarter. Finally, Conestoga Capital Advisors LLC boosted its stake in shares of Exponent by 6.2% in the third quarter. Conestoga Capital Advisors LLC now owns 582,852 shares of the company’s stock valued at $29,760,000 after buying an additional 34,235 shares in the last quarter. Institutional investors own 92.79% of the company’s stock.
Shares of Exponent Inc. (NASDAQ:EXPO) traded up 0.72% during midday trading on Friday, hitting $62.90. The company’s stock had a trading volume of 39,918 shares. The firm has a 50-day moving average of $56.50 and a 200 day moving average of $53.60. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of 36.36 and a beta of 0.65. Exponent Inc. has a 12-month low of $44.82 and a 12-month high of $63.30.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Wednesday, October 19th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.34 by $0.08. Exponent had a return on equity of 15.72% and a net margin of 15.06%. The firm earned $77.60 million during the quarter, compared to analysts’ expectations of $74.46 million. During the same quarter last year, the firm earned $0.43 earnings per share. The business’s revenue for the quarter was down .4% on a year-over-year basis. On average, equities research analysts predict that Exponent Inc. will post $1.70 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 23rd. Investors of record on Friday, December 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $0.72 annualized dividend and a dividend yield of 1.14%. Exponent’s dividend payout ratio is presently 41.86%.
Several brokerages have weighed in on EXPO. Cantor Fitzgerald set a $57.00 target price on Exponent and gave the stock a “buy” rating in a report on Thursday, October 20th. Zacks Investment Research upgraded Exponent from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 20th.
In related news, Director Michael R. Gaulke sold 8,750 shares of the stock in a transaction that occurred on Thursday, October 20th. The stock was sold at an average price of $55.14, for a total value of $482,475.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen C. Riggins sold 2,386 shares of the stock in a transaction that occurred on Tuesday, October 25th. The shares were sold at an average price of $56.95, for a total value of $135,882.70. Following the completion of the sale, the director now directly owns 2,650 shares of the company’s stock, valued at approximately $150,917.50. The disclosure for this sale can be found here. 3.50% of the stock is owned by corporate insiders.
Exponent Company Profile
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.